|
ZNF516 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.018120E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.244300E-04 |
| Normal-vs-Stage2 |
5.040400E-02 |
| Normal-vs-Stage3 |
6.638300E-02 |
| Normal-vs-Stage4 |
8.926400E-02 |
| Stage1-vs-Stage2 |
4.066400E-01 |
| Stage1-vs-Stage3 |
2.874200E-01 |
| Stage1-vs-Stage4 |
6.401200E-01 |
| Stage2-vs-Stage3 |
9.267400E-01 |
| Stage2-vs-Stage4 |
9.063400E-01 |
| Stage3-vs-Stage4 |
8.547000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.882770E-03 |
| Normal-vs-AfricanAmerican |
1.723840E-03 |
| Normal-vs-Asian |
5.444500E-03 |
| Caucasian-vs-AfricanAmerican |
7.604000E-01 |
| Caucasian-vs-Asian |
3.161800E-01 |
| AfricanAmerican-vs-Asian |
1.702370E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.959360E-04 |
| Normal-vs-Female |
4.780500E-02 |
| Male-vs-Female |
1.306250E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.192100E-02 |
| Normal-vs-Extreme_Weight |
9.7734000000016E-05 |
| Normal-vs-Obese |
9.243900E-03 |
| Normal-vs-Extreme_Obese |
8.230300E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.467600E-01 |
| Normal_Weight-vs-Obese |
9.661400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.587600E-01 |
| Extreme_Weight-vs-Obese |
1.601250E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.364000E-01 |
| Obese-vs-Extreme_Obese |
9.740200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.659800E-02 |
| Normal-vs-Age(41-60Yrs) |
3.893800E-02 |
| Normal-vs-Age(61-80Yrs) |
4.32300000000607E-05 |
| Normal-vs-Age(81-100Yrs) |
1.557490E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.107400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.877400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.556200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.303850E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.118200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.824400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.1827999999986E-05 |
| Normal-VS-Type2 PRCC |
1.739110E-03 |
| Normal-VS-KIRP CIMP |
7.495400E-01 |
| Normal-VS-Unclassified PRCC |
1.776750E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.150800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.917800E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.851960E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.986200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.488600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.524200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.2902999999852E-06 |
| Normal-vs-N1 |
4.208100E-02 |
| Normal-vs-N2 |
6.435600E-01 |
| N0-vs-N1 |
9.559900E-02 |
| N0-vs-N2 |
4.419200E-01 |
| N1-vs-N2 |
6.183000E-01 |
|
|
